InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Monday, 03/22/2021 10:26:19 AM

Monday, March 22, 2021 10:26:19 AM

Post# of 42752
Has anyone invested in KNSA since the trial came out showing that GM-CSF is the key to Covid? It seems likely that the government will put money toward an additional trial that includes several different drugs that are anti-GM-CSF. Lenz is obviously the top of the list. But Kiniksa's drug mavrilimumab also has a lot of potential. And their stock is down the last couple of sessions despite announcing FDA approval for recurrent pericarditis last Thursday night. I guess the news was already baked in but it should have popped a bit. No one on the KNSA stocktwits page is even talking about Covid treatment.

https://www.clinicaltrialsarena.com/comment/humanigens-and-kiniksas-anti-gm-csf-antibodies-likely-to-garner-a-place-for-nonventilated-covid-19-patients/